Does VILOXAZINE Cause Product dose omission issue? 28 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Product dose omission issue have been filed in association with VILOXAZINE (QELBREE). This represents 3.3% of all adverse event reports for VILOXAZINE.
28
Reports of Product dose omission issue with VILOXAZINE
3.3%
of all VILOXAZINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product dose omission issue From VILOXAZINE?
Of the 28 reports.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VILOXAZINE. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does VILOXAZINE Cause?
Headache (108)
Vomiting (95)
Nausea (92)
Migraine (82)
Fatigue (81)
Insomnia (75)
Somnolence (70)
Suicidal ideation (64)
Withdrawal syndrome (46)
Anxiety (44)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which VILOXAZINE Alternatives Have Lower Product dose omission issue Risk?
VILOXAZINE vs VIMPAT
VILOXAZINE vs VIMSELTINIB
VILOXAZINE vs VINBLASTINE
VILOXAZINE vs VINCRISTINE
VILOXAZINE vs VINDESINE